期刊文献+

植入型心律转复除颤器除颤电极导线功能故障的原因及处理

Causes and management of implantable cardiac defibrillator lead failure
下载PDF
导出
摘要 目的 探讨植入型心律转复除颤器(ICD)及心脏再同步化心律转复除颤器(CRT-D)除颤电极导线功能故障的发生率、可能原因及处理方法.方法 对166例植入ICD或CRT-D的患者进行长期跟踪随访,统计除颤电极导线功能故障发生率,分析其可能原因及处理方法.结果 166例患者中出现除颤电极导线功能故障5例,发生率为3.01%.其中电极导线绝缘层破裂1例,ICD导线功能障碍1例,R波感知逐渐降低3例.其中2例予以更换除颤电极导线,2例予以植入普通主动固定电极导线,余1例随访中待择期处理.结论 植入ICD或CRT-D的患者,除颤电极导线功能障碍可引起ICD不适当放电,随访中若发现除颤电极导线功能障碍,应及时更换导线. Objective To examine the incidence, causes, and management of defibrillation leads failure of implanted cardiac defibrillators (ICD) and cardiac resynchronization therapy plus defibrillator (CRT-D) devices. Methods One hundred and sixty-six patients with implanted ICD or CRT-D were followed up. Results Five out of 166 patients presented defibrillation lead failure with a incidence rate of 3.01%. Among 5 cases 1 had insulation defects, 1 had lead functional failure and 3 had T-wave suppression feature. New defibrillation lead was implanted in 2 patients and active-fixation pacing lead was implanted in another 2 patients. Conclusion Defibrillator lead failure can cause inappropriate shocks. It can be prevented by implantation of new defibrillator lead.
出处 《浙江医学》 CAS 2011年第4期470-472,共3页 Zhejiang Medical Journal
关键词 埋藏式心律转复除颤器 电极导线故障 发生率 治疗 Defibrillators implantable Equipment failure Incidence Therapy
  • 相关文献

参考文献12

  • 1A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.The Antiarrhythmics versus Implantable Defibrillators(AVID)investigators[J].N Engl J Med,1997,337(22):1576-1583.
  • 2王方正,张澍,任自文,郭继鸿,胡大一,陈新,中华医学会心电生理和起搏分会及中国生物医学工程学会心脏起搏与电生理分会ICD专家工作组.植入型心律转复除颤器治疗的适应证[J].中华心律失常学杂志,2002,6(4):198-206. 被引量:29
  • 3陈柯萍,陈若菡,王方正,华伟,张澍.植入型心律转复除颤器不适当识别和治疗的发生率及常见原因[J].中华心律失常学杂志,2006,10(6):409-413. 被引量:15
  • 4Korte T,Jung W,Spehl S,et al.Incidence of ICD lead related complications during long-term follow-up:comparison of epicardial and endocardial electrode systems[J].Pacing Clin Electrophysiol,1995,18(11):2053-2061.
  • 5Korte T,Jung W,Ostermann G,et al.Hospital readmission after transvenous cardioverter/defibrillator implantation; a single centre study[J].Eur Heart J,2000,21(14):1186-1191.
  • 6Green U B,Garg A,Al-Kandari F,et al.Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing[J].J Interv Card Electrophysiol,2003,8(1):71-75.
  • 7Rauwolf T,Guenther M,Hass N,et al.Ventricular oversensing in 518 patients with implanted cardiac defibrillators:incidence,complications,and solutions[J].Europace,2007,9(11):1041-1047.
  • 8Kleemann T,Becker T,Doenges K,et al.Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years[J].Circulation,2007,115(19):2474-2480.
  • 9Krishen A,Shepard R K,Leffler J A,et al.Implantable cardioverter defibrillator T wave oversensing caused by hyperglycemia[J].Pacing Clin Electrophysiol,2001,24(11):1701-1703.
  • 10Hauser R G,Kallinen L M,Almquist A K,et al.Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead[J].Heart Rhythm,2007,4(7):892-896.

二级参考文献75

  • 1Mower MM, Swerdlow C, Mandel WJ, et al. Use of the automatic implantable cardiovertor defibrillators in the treatment of malignant ventricular tachyarrhythmias. In: Willium J Mander, ed. Cardiac Arrhythmias: Their Mechanism, Diagnosis, and Management. 3rd ed. Philadelphia: J B Lippingcott Company, 1995.
  • 2Mirowski M, Mower MM, Staewen WS, et al. Standby automatic defibrillator: An approach to prevention of sudden coronary death. Arch Intern Med, 1970, 126: 150161.
  • 3Wichter T, Block M, Bocker D, et al. Cardioverter defibrillator therapy in a high risk subgroup of patients with arrhythmogenic right ventricular disease. J Am Coll Cardiol, 1993, 21:127A.
  • 4Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation, 1992, 85 (Suppl Ⅰ ) :157-163.
  • 5Kaminer SJ, Pickoff AS, Dunnigan A, et al. Cardiomyopathy and the use of implanted cardiac-defibrillators in children. Pacing Clin Electrophysiol, 1990, 13:593597.
  • 6Brugada P, Brugada J. Right bundle-branch block, persistent ST segment elevation and sundden cardiac death:distinct clinical and electrocardiography syndrom. A multicenter report. J Am Coll Cardiol, 1992, 20: 13911396.
  • 7Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST segment elevation in lead V1, through V3:a marker for sudden death in patients without demonstrable structural heart disease. Circulation, 1998, 47: 457460.
  • 8Brugada P, Brugada R, Brugada J. Sudden death in patients and relatives with the syndrome of right bundle branch block. ST segment elevation in the precordial leads V1 to V3 and sudden death. Eur Heart J, 2000, 21:321-326.
  • 9Atratashi H, Dgawa S, Harumi K, et al. Characteristic of patients with right bundle-branch block and ST segment elevation in right precordial leads. Am J Cardiol, 1996,78: 581-583.
  • 10Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implantable automatic defibrillator in human beings. N Engl J Med,1980, 303: 322-324.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部